Through dedication and innovation, Second Sight's mission is to develop, manufacture and market implantable visual prosthetics to enable blind individuals to achieve greater independence. Second Sight recently announced the first successful implant of a mechanical model of the Orion(TM) I Visual Cortical Prosthesis ("Orion I") in an animal study. The Orion I technology is based on the FDA-approv...ed Argus(R) II Retinal Prosthesis System ("Argus II"), but with updates to the electrode neural interface moving from the retina to the visual cortex. Implanted on the surface of the visual cortex located within the occipital lobe of the brain, Orion will bypass the retina and optic nerve altogether. This potentially offers hope for treating patients with nearly all forms of blindness where the optic nerve or retina is completely damaged, as in glaucoma, diabetic retinopathy, retinal detachments, trauma, infection, and others. The population of legally blind people potentially eligible for the Orion I is about 6 million worldwide.